We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 81

Biosimilars in Israel: Substantial Revisions to the Regulatory Scheme
  • Gilat, Bareket & Co., Reinhold Cohn Group
  • Israel
  • June 20 2016

In May 2016, Israel's Ministry of Health ("MoH") published substantial revisions to the guidelines appearing in Procedure No. 127, which regulates

A new policy regarding the registration and use of bio-similar pharmaceuticals in Israel
  • Reinhold Cohn Group
  • Israel
  • June 8 2014

On April 2014, the Israeli Ministry of Health ("MoH") issued a new work procedure, no. 127, which provides for more structured and detailed policy

Chen Ben Dori- Alkan
  • Reinhold Cohn Group

Eran Bareket
  • Reinhold Cohn Group

Lynn Shapiro Snyder
  • Epstein Becker Green

Cynthia Larose
  • Mintz Levin

Sally Albertazzie
  • Steptoe & Johnson LLP